Ledger.Open graph →
SEC Form D · filed January 13, 2026

ABLi Therapeutics, Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ATLANTA, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Jeffrey H. Young · Atlanta, GADirectorMilton H. Werner · Atlanta, GAExec · DirectorGarth H. Lees-Rolfe · Atlanta, GAExecAnastasia H. Daifotis · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗